The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PACB FINANCIAL STATEMENTS

Pacific Biosciences of California — balance sheet, income statement and cash flow trends

PACBPacific Biosciences of California

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M-250 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue159.3 M $Gross Profit57.3 M $ · 36%Operating Income-162.5 M $ · -102%Pre-tax Income-130.6 M $ · -82%Net Income to Owners-131.4 M $ · -82%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue159.3 M $+2.0%
Gross Profit57.3 M $+71.7%
Operating Income-162.5 M $—
EBITDA-109.1 M $—
Net Income to Owners-131.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets751.9 M
  • Current Liabilities68.8 M $9%
  • Long-term Liabilities716.3 M $91%

Key Figures

YoY change
Total Assets751.9 M $-8.9%
Total Liabilities785.1 M $+2.8%
Total Equity-33.2 M $-154.0%
Cash & ST Investments236.9 M $-24.7%
Total Debt706.1 M $+1.0%
Net Debt645.1 M $+0.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-150 M-100 M-50 M0-162.7 M $Operating156.7 M $Investing1.2 M $Financing-4.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow-162.7 M $—
Capital Expenditures8.6 M $-8.1%
Free Cash Flow-171.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PACB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.